Related references
Note: Only part of the references are listed.Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide
Weiqian Zhang et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Green tea extract alleviates arsenic-induced biochemical toxicity and lipid peroxidation in rats
Mahfoud Messarah et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2013)
Elevated risk of hypertension induced by arsenic exposure in Taiwanese rural residents: possible effects of manganese superoxide dismutase (MnSOD) and 8-oxoguanine DNA glycosylase (OGG1) genes
Shiuan-Chih Chen et al.
ARCHIVES OF TOXICOLOGY (2012)
Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-κB, and MAPK pathways
Lisu Wang et al.
ARCHIVES OF TOXICOLOGY (2012)
Finding a Target for Resveratrol
Ruth I. Tennen et al.
CELL (2012)
Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury
Joseph H. Holthoff et al.
KIDNEY INTERNATIONAL (2012)
Assessing the Threshold for the Duodenal GSH/GSSG Ratio in the Mouse Associated With Sodium Dichromate Dihydrate Ingestion Reported by Thompson et al. (2011)
Alan H. Stern
TOXICOLOGICAL SCIENCES (2012)
Genetic variants associated with arsenic metabolism within human arsenic (+3 oxidation state) methyltransferase show wide variation across multiple populations
Junko Fujihara et al.
ARCHIVES OF TOXICOLOGY (2011)
Mouse Arsenic (+3 Oxidation State) Methyltransferase Genotype Affects Metabolism and Tissue Dosimetry of Arsenicals after Arsenite Administration in Drinking Water
Baowei Chen et al.
TOXICOLOGICAL SCIENCES (2011)
Arsenic trioxide - An old drug rediscovered
Ashkan Emadi et al.
BLOOD REVIEWS (2010)
Inhibition by methylated organoarsenicals of the respiratory 2-oxo-acid dehydrogenases
Erik R. Bergquist et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2009)
Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo
X-Y Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Resveratrol attenuates cisplatin-induced nephrotoxicity in rats
Catia Lira Do Amaral et al.
ARCHIVES OF TOXICOLOGY (2008)
Genetic polymorphisms influencing arsenic metabolism:: Evidence from Argentina
Karin Schlawicke Engstrom et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2007)
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
Sharmila Shankar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215)
T. Sakurai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling
O Kutuk et al.
TOXICOLOGICAL SCIENCES (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat
JM Giraudel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19
T Hayakawa et al.
ARCHIVES OF TOXICOLOGY (2005)
Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport
C Cojocel et al.
ARCHIVES OF TOXICOLOGY (2004)
Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats
X Cui et al.
TOXICOLOGICAL SCIENCES (2004)
Oxidative mechanism of arsenic toxicity and carcinogenesis
HL Shi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA
T Schwerdtle et al.
CARCINOGENESIS (2003)
Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines
K Davison et al.
LEUKEMIA (2003)
Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity
AI Morales et al.
ANTIOXIDANTS & REDOX SIGNALING (2002)
Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma
J Vuky et al.
INVESTIGATIONAL NEW DRUGS (2002)
The cellular metabolism and systemic toxicity of arsenic
DJ Thomas et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide
P Westervelt et al.
BLOOD (2001)
Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys
L Giovannini et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
History of the development of arsenic derivatives in cancer therapy
S Waxman et al.
ONCOLOGIST (2001)
The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic
SV Kala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oval or injected inorganic arsenicals
J Liu et al.
TOXICOLOGICAL SCIENCES (2000)
Share Paper
